Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press118710.17650/1726-9776-2006-2-2-61-63DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCERДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак предстательной железыEfficiency of refresher courses of systemic (89SrCL2) radiotherapy for metastatic prostate cancerЭффективность повторных курсов системной лучевой терапии (89SrCl2) при метастатическом раке предстательной железыKiselevYe. N.КиселевЕ. Н.
Russian Federation

Saint Petersburg

Санкт-Петербург

KorytovaL. I.КорытоваЛ. И.
Russian Federation

Saint Petersburg

Санкт-Петербург

KarelinM. I.КарелинМ. И.
Russian Federation

Saint Petersburg

Санкт-Петербург

Central Research Institute of Radiology, Ministry of Health and Social Development of the Russian FederationФГУ Центральный научно-исследовательский рентгенорадиологический институт МЗ и СР РФ300620062261631802202018022020https://oncourology.abvpress.ru/oncur/article/view/1187

For patients with metastatic prostate cancer, palliative treatment is largely based on relief of skeletal pain. To evaluate a palliative effect and to reveal the positive and negative effects of a refresher course of systemic radiotherapy with strontium-89 chloride (89SrCl2), the authors assessed the results of comprehensive examination and the parameters of life quality in patients with metastatic prostate cancer who had taken 2—3 courses of systemic (89SrCl2) radiotherapy.

.